Cognition enhancing effect of panax ginseng in Korean volunteers with mild cognitive impairment: a randomized, double-blind, placebo-controlled clinical trial
Translational and Clinical Pharmacology · 2019 · 27 (3) · 92
DOI: 10.12793/tcp.2019.27.3.92 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational and Clinical Pharmacology, 2019. Verfasst von Key-Chung Park und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, College of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Rural Development Administration.
Abstract (Originalsprache)
This study aimed to investigate the cognition-enhancing effect of Panax ginseng. A randomized, double-blind, placebo-controlled clinical trial was conducted to address the cognition-enhancing effects of Panax ginseng. A total of 90 Korean volunteers with mild cognitive impairment participated in this study. All subjects were allocated randomly into 'Ginseng' group or 'Placebo' group. All subjects were administered 3g of Panax ginseng powder or starch (placebo) for 6 months. The Korean version of the Mini-Mental Status Examination (K-MMSE), Korean version of Instrumental Activities of Daily Living (K-IADL), and Seoul Neuropsychological Screening Battery (SNSB) were used to assess the changes in cognitive function at the end of the 6 month study period. The subjects of the 'Ginseng' group improved significantly on the Rey Complex Figure Test (RCFT) immediate recall (P = 0.0405 and P = 0.0342 in per-protocol (PP) and intention-to-treat (ITT) analysis, respectively) and on the RCFT 20-min delayed recall (P = 0.0396 and P = 0.0355 in PP and ITT analysis, respectively) compared with 'placebo' group throughout the 6 months of Panax ginseng administration. There were no serious adverse events. These results suggest that Panax ginseng has a cognition-enhancing effect.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, College of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
- Department of Clinical Pharmacology and Therapeutics, College of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
- Graduate School, Dankook University, Gyeonggi-do 16890, Republic of Korea.
- Department of Herbal Crop Research, National Institute of Horticultural & Herbal Science, Rural Development Administration, Eumseong 27709, Republic of Korea.
- East-West Medical Research Institute, Kyung Hee University, Seoul 02447, Republic of Korea.
ORCID-Profile: Key-Chung Park, Hui Jin, Renhua Zheng, Sehyun Kim, Seung-Eun Lee, Bo-Hyung Kim, Sung-Vin Yim
Förderung
- Rural Development Administration
Zitieren
APA
Park, K. C., Jin, H., Zheng, R., Kim, S., Lee, S. E., Kim, B. H., & Yim, S. V. (2019). Cognition enhancing effect of panax ginseng in Korean volunteers with mild cognitive impairment: a randomized, double-blind, placebo-controlled clinical trial. Translational and Clinical Pharmacology, 27(3), 92. https://doi.org/10.12793/tcp.2019.27.3.92
Vancouver
Park KC, Jin H, Zheng R, Kim S, Lee SE, Kim BH, et al. Cognition enhancing effect of panax ginseng in Korean volunteers with mild cognitive impairment: a randomized, double-blind, placebo-controlled clinical trial. Translational and Clinical Pharmacology. 2019;27(3):92. doi:10.12793/tcp.2019.27.3.92
BibTeX
@article{Park2019,
author = {Park, Key-Chung and Jin, Hui and Zheng, Renhua and Kim, Sehyun and Lee, Seung-Eun and Kim, Bo-Hyung and Yim, Sung-Vin},
title = {Cognition enhancing effect of panax ginseng in Korean volunteers with mild cognitive impairment: a randomized, double-blind, placebo-controlled clinical trial},
journal = {Translational and Clinical Pharmacology},
year = {2019},
volume = {27},
number = {3},
pages = {92},
doi = {10.12793/tcp.2019.27.3.92}
}
EUVIMED